Patents by Inventor Daniel Mulhern

Daniel Mulhern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-IL1RAP ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    Publication number: 20220267455
    Abstract: Disclosed herein are Interleukin 1 Receptor Accessory Protein (IL1RAP) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Application
    Filed: December 22, 2021
    Publication date: August 25, 2022
    Inventors: Tinglei Gu, Scott Michael Lonning, Jason G. Beaudet, Sean A. Beausoleil, Nels Eric Pederson, Daniel Mulhern
  • Anti-IL1RAP antibodies and antibody drug conjugates
    Patent number: 11248054
    Abstract: Disclosed herein are Interleukin 1 Receptor Accessory Protein (IL1RAP) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: February 15, 2022
    Assignee: BLUEFIN BIOMEDICINE, INC.
    Inventors: Tinglei Gu, Scott Michael Lonning, Jason G. Beaudet, Sean A. Beausoleil, Nels Eric Pederson, Daniel Mulhern
  • ANTI-IL1RAP ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    Publication number: 20200140561
    Abstract: Disclosed herein are Interleukin 1 Receptor Accessory Protein (IL1RAP) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Application
    Filed: June 12, 2018
    Publication date: May 7, 2020
    Inventors: Tinglei Gu, Scott Michael Lonning, Jason G. Beaudet, Sean A. Beausoleil, Nels Eric Pederson, Daniel Mulhern
  • Methylation and acetylation sites
    Patent number: 9856315
    Abstract: The disclosure features over 5000 methylation and acetylation sites identified in human cell line, human serum and mouse tissues, peptides (including AQUA peptides) comprising a methylation or acetylation site of the disclosure, antibodies specifically bind to a methylation or acetylation site of the disclosure, and diagnostic and therapeutic uses of the above.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: January 2, 2018
    Assignee: Cell Signaling Technology, Inc.
    Inventors: Hongbo Gu, Ailan Guo, Daniel Mulhern, Jeffrey C. Silva, Jing Zhou
  • Methylation and Acetylation Sites
    Publication number: 20160137725
    Abstract: The disclosure features over 5000 methylation and acetylation sites identified in human cell line, human serum and mouse tissues, peptides (including AQUA peptides) comprising a methylation or acetylation site of the disclosure, antibodies specifically bind to a methylation or acetylation site of the disclosure, and diagnostic and therapeutic uses of the above.
    Type: Application
    Filed: October 15, 2015
    Publication date: May 19, 2016
    Inventors: Hongbo Gu, Ailan Guo, Daniel Mulhern, Jeffrey C. Silva, Jing Zhou